Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

VRTX

Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VRTX
DateTimeSourceHeadlineSymbolCompany
05/20/20242:32PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
05/20/20247:36AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRTXVertex Pharmaceuticals Inc
05/20/20247:25AMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:VRTXVertex Pharmaceuticals Inc
05/17/20243:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
05/17/20243:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
05/17/20243:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
05/17/20243:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
05/17/20243:16PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
05/16/20243:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
05/15/202411:20AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
05/15/202410:50AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
05/15/202410:41AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRTXVertex Pharmaceuticals Inc
05/15/20249:30AMBusiness WireJennifer Schneider Elected to Vertex Board of DirectorsNASDAQ:VRTXVertex Pharmaceuticals Inc
05/10/20247:01AMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:VRTXVertex Pharmaceuticals Inc
05/08/20247:54AMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:VRTXVertex Pharmaceuticals Inc
05/07/20243:14PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VRTXVertex Pharmaceuticals Inc
05/07/20246:46AMIH Market NewsDisney Slashes Streaming Losses, UBS shoots up 9% as profit triples expectations, and More in EarningsNASDAQ:VRTXVertex Pharmaceuticals Inc
05/06/20243:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRTXVertex Pharmaceuticals Inc
05/06/20243:01PMBusiness WireVertex Reports First Quarter 2024 Financial ResultsNASDAQ:VRTXVertex Pharmaceuticals Inc
05/06/20247:09AMIH Market NewsIndex Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices RiseNASDAQ:VRTXVertex Pharmaceuticals Inc
04/26/202410:43AMBusiness WireVertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and OlderNASDAQ:VRTXVertex Pharmaceuticals Inc
04/22/202411:45PMPR Newswire (Canada)VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETESNASDAQ:VRTXVertex Pharmaceuticals Inc
04/22/202411:45PMPR Newswire (US)VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETESNASDAQ:VRTXVertex Pharmaceuticals Inc
04/22/202411:45PMPR Newswire (US)VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETESNASDAQ:VRTXVertex Pharmaceuticals Inc
04/18/20247:00AMBusiness WireVertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic PainNASDAQ:VRTXVertex Pharmaceuticals Inc
04/11/20246:24AMIH Market NewsCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’ AI Chip, and More NewsNASDAQ:VRTXVertex Pharmaceuticals Inc
04/10/20243:01PMBusiness WireVertex Enters Into Agreement to Acquire Alpine Immune SciencesNASDAQ:VRTXVertex Pharmaceuticals Inc
04/10/20243:01PMBusiness WireVertex Enters Into Agreement to Acquire Alpine Immune SciencesNASDAQ:VRTXVertex Pharmaceuticals Inc
04/09/20243:05PMBusiness WireVertex to Announce First Quarter 2024 Financial Results on May 6NASDAQ:VRTXVertex Pharmaceuticals Inc
04/01/202410:00AMPR Newswire (Canada)Vertex Announces New Drug Submission for Exagamglogene Autotemcel (exa-cel) Has Been Accepted for Priority Review by Health Canada for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta ThalassemiaNASDAQ:VRTXVertex Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VRTX